Dwatro Laboratories sp. z o.o.

Manufacture of homogenised food preparations and dietetic food

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2021-06-14
Share capital
5,000.00 PLN
Activity description

Dwatro Laboratories offers dietary supplements made with Dwatro Lip liposomal technology, in oral gel sachets. Developed by pharmacist and scientist Dorota Wątróbska-Świetlikowska, the range includes supplements for immunity, joints, eyes, hair and sleep, without sugar, sweeteners, preservatives or fillers.

Registered address
ul. Hutnicza 36B, 81-061 Gdynia, Poland
Opening hours
Mon–Fri, 9:00–18:00
Phone
Social media
Electronic delivery address
AE:PL-77574-93289-URABI-23

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$70,284
Profit allocationRetained in reserve capital

Filing timeliness

2 of 5 financial statements were filed late (the longest delay 84 days for 2021).

  • 202508/07/2026
  • 202428/06/2025
  • 202328/06/2024
  • 202217/07/2023
  • 202107/10/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Division · Manufacture of food products1,974 / 3,419
Top 58%
Sector · Manufacturing11,876 / 24,649
Top 48%
City · Gdynia899 / 3,598
Top 25%
Voivodeship · Pomorskie5,417 / 20,095
Top 27%
Country · Poland82,106 / 298,026
Top 28%

Results vs industry

Revenue
This companyUSD 1.22mMedianUSD 483.69kAverageUSD 6.67m
Net profit
This companyUSD 688.57kMedianUSD 12.34kAverageUSD 529.42k
Operating costs
This companyUSD 452.37kMedianUSD 492.39kAverageUSD 5.87m
Assets
This companyUSD 1.81mMedianUSD 421.84kAverageUSD 5.98m

Offer

Websites

The site is available in: Polish, English and Lithuanian.

  • dwatrolaboratories.comLiposomalne suplementy diety w żelu – DWATRO Laboratories
    WooCommerceWordPress 3.7WebflowGoogle Tag ManagerYoast SEOWPMLCloudflare

Authorized Representatives

Tadeusz Sławomir Wątróbski age 72 – President of the Management Board

Manner of representation

Each member of the management board is authorized to submit declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
10$135.0610%
90$1,215.5690%

Dorota Anna Wątróbska-Świetlikowska and Ewa Wątróbska hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Sanctions and PEP

Sanctions

No matches (EU, UN, US, UK, MSWiA, World Bank)

PEP

No matches

Bank accounts

Registered as a VAT taxpayer on 2020-07-15.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$48,616

Competitors

Name
Flavon Group Polska sp. z o.o.
Invex Remedies sp. z o.o.
Nathealth sp. z o.o.
Pharma Nord sp. z o.o.
Nutri Partner sp. z o.o.
IOC sp. z o.o.
Hepatica sp. z o.o.
Labify sp. z o.o.
Medso sp. z o.o.
Medcalm sp. z o.o.

Change history

DateEvent
2022-10-18PKD change
2021-06-14Entered in the register

FAQ

Last updated: 2026-07-10